SEIKAGAKU CORPORATION Overview
Company Headquarters: Tokyo, Japan
Founded: 1947
Workforce: ~744
Company Working: Seikagaku Corporation is a leading pharmaceutical and medical devices company in Japan. It operates through two business segments, namely pharmaceuticals and limulus amebocyte lysate (LAL). The pharmaceuticals segment manufactures cross-linked ophthalmic surgical aids, hyaluronate hydrogel for knee osteoarthritis, intra-articular injections for improving joint functions, and surgical aids for endoscopic mucosal resection. The LAL business segment is engaged in the production and distribution of endotoxin-detecting reagents made from LAL. The company has a pharmaceuticals manufacturing plant in Japan and endotoxin detecting manufacturing plant in the US. The Takahagi Plant owned by Seikagaku Corporation located in northern Ibaraki Prefecture (Japan) is engaged in the manufacturing of finished pharmaceutical products and medical devices. The other two production sides include Associates of Cape Cod, Inc (US) and Kurihama Plant (Japan).
Strategy
Sinopec Corporation is focusing on R&D, optimizing resource allocation, and increasing the operating profit. It is planning to invest in new manufacturing technologies for developing high-quality pharmaceuticals.
